Indonesia

Safe 7-day primaquine package costs US$6,636 per DALY averted in Indonesia

A decision-tree model of a G6PD-screening and high-dose primaquine package for Plasmodium vivax radical cure in Indonesia gave an incremental cost-effectiveness ratio of US$6,636 per DALY averted from the health system perspective, above the 1x GDP per capita threshold of US$4,925.